Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.50 |
| ▸ | BMP1 | P13497 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 4/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3894738 | 0.93 | ECE1 (0.52) | ECE1NOD1BMP1BACE1ENPEP | |
| SCHEMBL29482767 | 0.93 | ECE1 (0.52) | ECE1NOD1BMP1BACE1ENPEP | |
| SCHEMBL5324609 | 0.93 | BMP1 (0.50) | ECE1NOD1BMP1DPP4DPP8 | |
| SCHEMBL2503880 | 0.92 | NOD1 (0.57) | ECE1NOD1BMP1DPP4DPP8 | |
| SCHEMBL2503883 | 0.92 | NOD1 (0.57) | ECE1NOD1BMP1DPP4DPP8 | |
| SCHEMBL29959381 | 0.92 | NOD1 (0.46) | ECE1NOD1BMP1DPP4DPP8 | |
| Alanyl Glutamine SCHEMBL4274839 | 0.89 | NOD1 (0.59) | ECE1NOD1BMP1DPP4DPP8 | |
| Alanyl Glutamine SCHEMBL133887 | 0.89 | NOD1 (0.59) | ECE1NOD1BMP1DPP4DPP8 | |
| Alanyl Glutamine SCHEMBL31140886 | 0.89 | NOD1 (0.59) | ECE1NOD1BMP1DPP4DPP8 | |
| Alanyl Glutamine SCHEMBL8427100 | 0.89 | NOD1 (0.59) | ECE1NOD1BMP1DPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | claimed |
| WO-2007139433-A8 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTV (RU) | 2009-07-16 | — | — | WO | disclosed |
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | disclosed |
| US-4426324-A | Immunopotentiating peptides | HOFFMANN-LA ROCHE INC. (US) | 1984-01-17 | — | — | US | disclosed |